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 Title: Imposed faster and slower walking speeds influence gait stability 1 
differently in Parkinson fallers 2 
 3 
ABSTRACT 4 
Objective: This cross-sectional study sought to evaluate the effect of imposed faster and 5 
slower walking speeds on postural stability in people with Parkinson’s disease (PD). 6 
 7 
Design: Cross-sectional cohort study 8 
 9 
Setting: General community 10 
 11 
Participants: 84 PD patients (51 with a falls history; 33 without) and 82 age-matched 12 
controls were invited to participate via neurology clinics and pre-existing databases.  Of those 13 
contacted, 99 did not respond (PD=36; controls=63) and 27 were not interested (PD=18; 14 
controls=9). Following screening, a further 10 patients were excluded; 5 had deep brain 15 
stimulation surgery and 5 could not accommodate to the treadmill. The remaining 30 patients 16 
completed all assessments and were sub-divided in PD fallers (n=10), PD Non-Fallers (n=10) 17 
and age-matched controls (n=10) based on falls history. 18 
 19 
Protocol: Symptom severity, balance confidence and medical history were established prior 20 
to participants walking on a treadmill at 70%, 100% and 130% of their preferred speed.  21 
 22 
Main Outcomes: Three-dimensional accelerometers assessed head and trunk accelerations 23 
and allowed calculation of harmonic ratios (HRs) and root mean square (RMS) accelerations 24 
to assess segment control and movement amplitude. 25 
  26 
Results: Head and trunk control was lower for PD Fallers than PD Non-Fallers and Older 27 
Adults. Significant interactions indicated head and trunk control increased with speed for PD 28 
Non-Fallers and Older Adults, but did not improve at faster speeds for PD Fallers. Vertical 29 
head and trunk accelerations increased with walking speed for PD Non-Fallers and Older 30 
Adults, while the PD Fallers demonstrated greater anteroposterior RMS accelerations 31 
compared with both other groups. 32 
 33 
Conclusion: The results suggest that improved gait dynamics do not necessarily represent 34 
improved walking stability and this must be respected when rehabilitating gait in PD patients. 35 
 36 
Keywords: Gait; Segmental Control; Harmonic Ratio; Parkinson Disease; Falls  37 
 Parkinson’s disease (PD) is a debilitating neurodegenerative condition that is characterised by 38 
motor symptoms that include resting tremor
1
, slowness of movement
2
, muscle rigidity
2
, 39 
postural instability
2
, and gait disturbances (e.g. freezing of gait (FOG))
1
. Unfortunately, 40 
symptoms of postural instability and gait disability are only partially responsive to current 41 
pharmacological interventions
3
. In fact, research shows that, even when optimally-medicated, 42 
people with PD demonstrate more asymmetric movement patterns
4, 5
, walk more slowly
6-9
, take 43 
shorter strides
6-9
 and have less rhythmic acceleration profiles for the head
10
 and trunk
11
 44 
compared with age-matched controls. The changes in segmental rhythmicity appear to be 45 
related, at least in part, to deficits in neuromuscular control
12
 and seem to be more prominent 46 
in people with PD who prospectively report falls
13, 14
.  Given this apparent relationship 47 
between postural instability, gait disability and falls in people with PD and the obvious 48 
ineptitude of current pharmacological therapies, clinicians and scientists have sought to identify 49 
suitable alternatives to manage these symptoms. 50 
 51 
Treadmill-based gait retraining that incorporates auditory or visual cues has emerged as a 52 
common form of physical therapy and seeks to correct gait impairments in people with PD by 53 
increasing their stride length and, ultimately, their walking speed
15
. Importantly, the existing 54 
literature concerning gait retraining indicates that this form of therapy succeeds at this goal 55 
by helping patients to increase their stride length
16-21
, walking speed
17-23
 and walking 56 
distance
22
. Despite the established benefits of treadmill-based gait retraining for people with 57 
PD, the precise relationships between changes in walking speed and walking stability and/or 58 
falls risk are far less clear. For example, some prospective research has demonstrated that 59 
community-dwelling older adults who walk at slower (<0.6 m/s) or faster (≥1.3 m/s) speeds 60 
are at an increased risk of future falls
24
. Similar results were presented in a cross-sectional 61 
study involving healthy younger adults, which showed that slower and faster than preferred 62 
 speeds led to sub-optimal walking stability
25
.  However, despite these findings, a series of 63 
studies adopting non-linear analyses have suggested that local dynamic stability is 64 
significantly improved at slower walking speeds for healthy younger adults
26, 27
, older 65 
adults
28
 and patients with significant peripheral neuropathy
29, 30
.  Given these conflicting 66 
results, it remains unclear whether the slower walking speeds adopted by people with PD 67 
serve to optimise their dynamic stability or contribute to their increased risk of falling. An 68 
improved understanding of this relationship would help clinicians to better appreciate how 69 
changes to a patient’s walking speed might influence their stability and overall risk of falls.  70 
 71 
During dynamic tasks, the maintenance of equilibrium relies upon one’s capacity to control 72 
the movements of the head and trunk, which represent almost 60% of the body’s mass31, 32. 73 
From a functional perspective, the head is considered an important natural frame of reference, 74 
as it houses the organs responsible for the visual and vestibular information used in postural 75 
control and orientation
33-35
. The trunk is also believed to play a role in maintaining postural 76 
stability during locomotion, as it serves to attenuate movement-related forces that project 77 
upwards from the feet and threaten to destabilise the head
36, 37
. However, research reporting 78 
larger
12-14
 and less rhythmic
10, 11
 head and trunk movements for people with PD provides 79 
evidence to suggest that this population may have an impaired capacity to attenuate these 80 
forces. Support for this notion was recently provided in a study that demonstrated people with 81 
PD have an impaired capacity to attenuate accelerations from the pelvis and neck to the 82 
head
38
. This impairment is likely related to the increased axial rigidity that is evident in 83 
people with PD during standing
39
 and walking
40
, which is seemingly caused by differences in 84 
the activation patterns of the paraspinal muscles in this population
12
.  While it is widely 85 
recognised that the routine use of anti-parkinsonian medication can significantly improve 86 
some characteristics of gait
41, 42
, it is equally well-documented that the symptoms of axial 87 
 rigidity that contribute to postural instability and falls in this population are not well managed 88 
with traditional therapies
40, 43
.  Given this situation, there appears to be a clear need for 89 
research aimed at elucidating whether increasing walking speed in people with PD can be 90 
achieved without inadvertently influencing postural stability. As such, it was the purpose of 91 
this study to determine whether walking at speeds faster or slower than preferred reduces 92 
postural stability for people with PD.  Given that slower and faster walking speeds have been 93 
linked with a greater risk of falls in older adults
24
, it was hypothesised that walking at speeds 94 
other than one’s preferred walking speed would reduce postural stability and that this 95 
relationship would be more pronounced for participants with a history of falling. 96 
 97 
METHODS 98 
Study Population 99 
Between August and November 2014, 84 people clinically-diagnosed with idiopathic PD 100 
based on the Parkinson’s United Kingdom Brain Bank Criteria44 were invited to participate 101 
via community support groups and neurology clinics.  Over the same period, 82 age-matched 102 
older adults (Controls) from the Brisbane metropolitan area were contacted via an existing 103 
database of individuals who had expressed interest in contributing to research of this nature. 104 
Of those contacted, 99 did not respond (PD=36; Controls=63) and 27 were not interested 105 
(PD=18; Controls=9). The remaining 30 people with PD and 10 controls were screened and 106 
excluded if they had; i) recently undergone surgery; ii) a recurrent history of musculoskeletal 107 
injury; iii) an inability to walk without assistance; iv) significant visual (Bailey-Lovie high 108 
contrast visual acuity >0.30 logMAR) or cognitive (Addenbrooke’s Cognitive Examination 109 
score <82 out of 100
45
) impairment; or v) received deep brain stimulation. Following 110 
screening, 5 patients were excluded as they had received deep brain stimulation and 5 were 111 
excluded as they were unable to accommodate to the treadmill.  The remaining participants 112 
 reported the number of falls that they had experienced in the past year and these data were 113 
used to separate PD Fallers (n=10) from PD Non-Fallers (n=10) and Older Adults (n=10). In 114 
all cases, the PD Fallers attributed their falls directly to complications associated with the 115 
symptoms and/or treatment of their condition (e.g. freezing of gait; festination, retropulsion; 116 
postural instability), rather than to situations that might be considered typical for an otherwise 117 
healthy individual. Falls were assessed retrospectively and defined as any unintentional 118 
coming to the ground or some lower level not as a result of a major intrinsic event or 119 
overwhelming hazard
46
. 120 
 121 
An a-priori power calculation performed using data presented previously
11
 indicated that a 122 
sample size of 10 participants per group was sufficient to detect any significant changes in 123 
dynamic stability (diff = 0.05, SD = 0.04, Cohen’s d = 1.25, Power = 80%, p = 0.05). The 124 
experimental protocol was approved by the Human Research Ethics Committee at the 125 
Australian Catholic University and, in accordance with the Declaration of Helsinki, all 126 
participants gave written informed consent prior to participating in this research.
 
127 
 128 
INSERT TABLE 1 ABOUT HERE 129 
 130 
Clinical Assessment 131 
Prior to the gait assessment, details related to each participant’s falls history, medical history 132 
and current medications were collected via a brief health questionnaire, while balance 133 
confidence was assessed using the 6-item Activities-specific Balance Confidence scale
47
. 134 
Additionally, an experienced movement disorders researcher completed clinical assessments 135 
for the PD participants to establish each patient’s symptom severity and quality life. 136 
Specifically, symptom severity was assessed using the motor sub-scale of the Unified 137 
 Parkinson’s Disease Rating Scale (UPDRS III)48, the Hoehn and Yahr stage score49 and the 138 
Schwab and England Activities of Daily Living (ADL) scale
50
.  Additionally, FOG and 139 
quality of life were assessed using the Revised Freezing of Gait questionnaire
51
 and the 8-140 
item Parkinson’s Disease Questionnaire52, respectively.  By calculating the sum of the scores 141 
for the items relating to rigidity on the UPDRS III, a global rigidity score was determined 142 
using previously-described methods
53
. All procedures were completed while the PD patients 143 
were receiving their usual anti-parkinsonian treatment, with 10 PD Fallers (100%) and 9 PD 144 
Non-Fallers (90%) being treated with levodopa and/or dopamine agonists (Table 1). 145 
 146 
Apparatus 147 
Two wireless 6g microelectromechanical systems (MEMS) tri-axial accelerometers (Noraxon 148 
Inc., USA) were positioned over the occipital protuberance of the skull and the spinous 149 
process of the 10
th
 thoracic vertebra to measure head and trunk accelerations during treadmill 150 
walking.  The head accelerometer was attached to a firm-fitting headband, while the trunk 151 
accelerometer was firmly affixed to the skin using double-sided tape and Omnifix.  Head and 152 
trunk accelerations were sampled at 1500 Hz and telemetered wirelessly to a Telemyo DTS 153 
receiver connected to a laptop running the MyoResearch XP software (v1.08, Noraxon Inc., 154 
USA). Prior to attaching the equipment, a series of static trials were completed while each of 155 
the accelerometers’ axes were perpendicularly aligned with a horizontal surface to measure 156 
gravitational acceleration (1 gravitational unit or 1g) in the absence of movement
54
. 157 
 158 
The walking trials were completed on a Quasar motorised treadmill (HP Cosmos, DE) that 159 
had a moving surface size of 1.70 x 0.65 m (L x W) and an overhead safety frame fitted to 160 
facilitate anchoring of the participant safety harness. To ensure that participants were blind to 161 
their walking speed and to any changes that were made throughout the testing period, the user 162 
 terminal was rotated such that the participants were unable to see the electronic display. Prior 163 
to data collection, the validity of the treadmill’s belt speed was assessed using a three-164 
dimensional motion analysis system (T-Series cameras with Nexus 1.7; Vicon, UK) and was 165 
found to be accurate under both loaded and unloaded conditions at speeds ranging from 0.6 to 166 
2.0 m/s (mean error = ±0.03 m/s). 167 
 168 
Data Collection 169 
To ensure that they could safely ambulate on the treadmill, each participant completed a 170 
familiarisation period while wearing their own comfortable walking shoes and a safety vest 171 
that was attached to the overhead safety frame.  Each participant’s preferred walking speed 172 
was then determined during three independent trials that were each separated by a rest break 173 
of no less than 60 seconds. During these trials, the treadmill’s speed was systematically 174 
increased or decreased in 0.1 m/s increments based on the participant’s instruction until they 175 
reported that they were walking at a comfortable speed. The average walking speed for these 176 
three trials was considered to be representative of the participant’s preferred walking speed 177 
(100%) and was used to calculate the slower (70%) and faster (130%) walking conditions
26
. 178 
Using this information, participants completed a graded walking task that involved walking 179 
on the treadmill for 60 seconds at intensities that were equal to 70%, 100% and 130% of their 180 
preferred walking speed. To ensure that the acceleration/deceleration phase of each trial did 181 
not influence the reported outcomes, each 60-second data collection period did not 182 
commence until the treadmill had reached the target velocity and the participants reported 183 
having achieved a steady walking pattern.  Given people with PD experience greater 184 
symptoms of gait impairment
13, 14
 and fear of falling
55
, the order of walking speeds (Intensity) 185 
was progressed from slowest to fastest. Furthermore, to limit the potential influence of 186 
fatigue, each walking trial was separated by a mandatory 1-minute rest break.  187 
  188 
Data Analysis 189 
Following data collection, the raw three-dimensional head and trunk accelerations were 190 
transformed to a horizontal-vertical orthogonal coordinate system using an extrapolation of 191 
simple trigonometry
36
.  In short, transformation of the accelerations was required to correct 192 
for tilt in the AP and ML directions, such that the accelerometer’s vertical axis was realigned 193 
with the gravity vector (i.e. global vertical axis)
56
. The transformation algorithm achieved this 194 
by assuming that the head and trunk accelerometers were rotated (i.e. r(theta1, theta2)) and 195 
that this angle was constant throughout the trial. This assumption was guided by previous 196 
research, which reported that the orientation of the upper body changes minimally during 197 
gait
57, 58
 and, hence would only influence gait-related accelerations to a small degree
36, 59
. 198 
During pilot testing, the performance of the transformation process was assessed by 199 
comparing the transformed accelerations from the Noraxon system with data simultaneously 200 
collected using XSens inertial measurement units (IMUs). Data from the IMUs were rotated 201 
using the device’s internal gyroscope and comparison of the anteroposterior (AP), 202 
mediolateral (ML) and vertical (VT) acceleration profiles from the two systems returned 203 
correlation coefficients of 0.8 or greater for all three axes.  Following transformation, the 204 
timing of individual foot contacts was identified via the recurring peaks in the vertical trunk 205 
acceleration profile
11, 60, 61
 and used to crop each trial to a length that included 10 left and 10 206 
right gait cycles (i.e. 20 gait cycles total). The cropped data were then low-pass filtered using 207 
a fourth-order Butterworth filter with a cut-off frequency of 30 Hz
59, 62
.  208 
 209 
To examine changes in the rhythmicity of AP, ML and VT head and trunk accelerations at 210 
the different walking speeds, the harmonic ratio (HR) was calculated by firstly dividing the 211 
continuous data series into individual gait cycles (i.e. 20 per trial). Data for each gait cycle 212 
 were then converted to the frequency domain using the Fast Fourier Transformation, which 213 
allowed the harmonics of the signal’s fundamental frequency (i.e. stride frequency63) to be 214 
identified
64
.  As each gait cycle is comprised of two steps, the AP and VT acceleration 215 
profiles of a healthy individual are typically characterised by two comparable peaks
25
.  As 216 
these peaks repeat in multiples of two, the frequency spectra of AP and VT accelerations are 217 
dominated by the even harmonics (i.e. 2, 4), which represent the in-phase component of these 218 
signals. In contrast, ML accelerations are characterised by two opposing peaks; 1 219 
corresponding with a weight shift to the left leg and 1 corresponding with a weight shift to 220 
the right leg. This unique characteristic of the ML acceleration profile means that the odd 221 
harmonics (i.e. 1, 3) dominate this component and, hence represent the in-phase component 222 
of this signal. Using the first 20 harmonics for each gait cycle (i.e. 10 in-phase; 10 out-of-223 
phase), the AP, ML and VT harmonic ratios were calculated for the head and trunk by 224 
dividing the sum of the in-phase harmonics by the sum of the out-of-phase harmonics
64
. 225 
Given this calculation, larger HRs represent a greater proportion of in-phase accelerations 226 
relative to out-of-phase accelerations, which is indicative of greater movement rhythmicity 227 
and poorer segmental control
64, 65
. 228 
 229 
To provide insight into the amplitude of head and trunk accelerations during the walking task, 230 
the root mean square (RMS) amplitude of the time-series data for the AP, ML and VT 231 
accelerations was also calculated
66
.  In addition to the three-dimensional HRs and RMS 232 
accelerations, the timings of each individual foot contact were used to calculate a number of 233 
spatiotemporal characteristics. Specifically, cadence (steps/min) was assessed by determining 234 
the number of steps taken by each participant during the 60-second trial, while stride timing 235 
variability (ms) was derived by calculating the standard deviation of the time taken by the 236 
participant to complete each of the 20 gait cycles (i.e. stride time)
67, 68
.  Lastly, given that 237 
 walking speed is a composite measure representing stride length (i.e. distance) divided by 238 
stride time, stride length was calculated by multiplying walking speed (m/s) by stride time. 239 
These outcome measures were selected as they have been extensively used to assess walking 240 
in people with PD
11, 65, 69
 and have been previously shown to discriminate retrospective fallers 241 
from non-fallers in this population
10
. All processing of the raw head and trunk accelerations 242 
was performed using a custom Matlab program (R2015b, The MathWorks, USA). 243 
 244 
Statistical Analysis 245 
A one-way analysis of variance (ANOVA) was used to compare the groups for differences in 246 
demographics, falls history, fear of falling, quality of life and symptom severity. When a 247 
significant main effect was identified, the Tukey’s Honestly Significant Difference (HSD) 248 
post-hoc test was used to determine where the statistically significant differences existed. 249 
When the assumptions of ANOVA were violated, the non-parametric Kruskal-Wallis Test 250 
was used to compare the groups, while the degree of association between categorical 251 
variables was assessed using the chi-square (χ2) test.  252 
 253 
To determine mean differences between the PD Fallers, PD Non-Fallers and Older Adults for 254 
the accelerometer-based measures of gait rhythmicity and segmental motion, linear mixed 255 
model (LMM) analyses with one repeated (Intensity, 3 levels) and one fixed (group, 3 levels) 256 
factor were used. As gait speed and stride time variability both influence segmental 257 
accelerations
10
, both were entered as covariates for the analysis of HRs and RMS 258 
accelerations.  Furthermore, to determine whether differences in disease duration, symptom 259 
severity and/or medication use accounted for any differences in HRs or RMS accelerations, a 260 
series of sub-analyses were conducted for the PD Fallers and Non-Fallers, with these clinical 261 
scores also entered as covariates. Where significant main effects or interactions were 262 
 identified, Tukey’s Least Significant Difference post-hoc tests were used to conduct pairwise 263 
comparisons between the groups. All statistical procedures were conducted using SPSS v.22 264 
and the level of significance was set at p < 0.05. 265 
 266 
RESULTS 267 
Demographics and Clinical Assessments 268 
PD Fallers, PD Non-Fallers and Older Adults did not differ significantly with respect to age, 269 
gender distribution, height or mass, but PD Fallers had increased rigidity, poorer quality of 270 
life and greater symptom severity than patients in the PD Non-Faller group. PD Fallers also 271 
tended to report poorer balance confidence than the other participants (p=0.08) and to be 272 
taking larger daily doses of levodopa than PD Non-Fallers (p=0.06); however, these trends 273 
did not achieve statistical significance. Similarly, the PD Faller and Non-Faller groups were 274 
not different with respect to disease duration or the proportion of patients prescribed 275 
dopamine agonists, catechol-o-methyl transferase (COMT) inhibitors, monoamine oxidase 276 
inhibitors (MAOIs) and/or benzodiazepines (Table 1). 277 
 278 
Walking Assessment 279 
PD Fallers walked significantly slower and took significantly shorter strides, but did not 280 
differ from the PD Non-Fallers or Older Adults with respect to cadence and stride time 281 
variability. Significant main effects for Intensity indicated that stride length and cadence 282 
systematically increased from the 70% to 100% to 130% conditions, while stride time 283 
variability systematically decreased as walking speed increased (Figure 1). With respect to 284 
head and trunk rhythmicity, significant main effects for Intensity indicated that harmonic 285 
ratios were significantly reduced (poorer) during the 70% trials compared with the 100% and 286 
130% conditions. Furthermore, ML head and trunk rhythmicity was significantly improved 287 
 when participants walked at the 130% walking speed compared with their preferred walking 288 
speed (100%). Significant main effects for Group were reported for the ML and VT axes of 289 
head and the AP, ML and VT axes of the trunk. Post-hoc analyses revealed that PD Non-290 
Fallers recorded significantly lower head (ML, VT) and trunk (AP, ML, VT) rhythmicity than 291 
the Older Adults (Figure 2). Similarly, PD Fallers had significantly lower head (ML, VT) and 292 
trunk (AP, ML, VT) harmonic ratios than PD Non-Fallers and Older Adults and sub-analysis 293 
of the PD Fallers and Non-Fallers suggested that these findings were not attributable to 294 
differences in disease duration, symptom severity and/or daily levodopa equivalent dose.  295 
 296 
INSERT FIGURE 1 ABOUT HERE 297 
 298 
In addition to these main effects, significant Group*Intensity interactions were reported for 299 
AP and VT harmonic ratios for the head and AP, ML and VT harmonic ratios for the trunk. 300 
Further examination of these interactions showed that the speed-related changes in head and 301 
trunk rhythmicity for PD Fallers were significantly different to those observed for PD Non-302 
Fallers and Older Adults. Specifically, head AP and VT harmonic ratios for the PD Non-303 
Fallers and Older Adults significantly increased as walking speed increased. An improvement 304 
in AP and VT head rhythmicity between the 70% and 100% walking speeds was also evident 305 
for the PD Fallers, but AP head rhythmicity was unchanged between the 100% and 130% 306 
conditions, while VT head rhythmicity declined at the faster speed. Similarly, AP, ML and 307 
VT trunk harmonic ratios remained unchanged or improved as walking speed increased for 308 
the PD Non-Fallers and Older Adults, while both AP and VT trunk harmonic ratios were 309 
significant reduced for the PD Fallers during the 130% walking trial, compared with the 310 
100% condition (Table 2).  311 
 312 
 INSERT FIGURES 2 AND 3 ABOUT HERE 313 
 314 
The RMS accelerations demonstrated that PD Fallers had significantly greater AP head 315 
accelerations than PD Non-Fallers and Older Adults, but were not dissimilar with respect to 316 
any other component of head or trunk acceleration. The sub-analyses conducted for the two 317 
PD groups indicated that the larger RMS head accelerations (AP) recorded for the PD Fallers 318 
were largely explained by differences in disease duration, symptom severity and/or levodopa 319 
daily equivalent doses. Significant main effects for Intensity suggested that AP and ML head 320 
accelerations and ML trunk accelerations were significantly greater during the 70% condition 321 
relative to the 100% and 130% walking trials (Figure 3). In contrast, VT RMS accelerations 322 
for the head and trunk were significantly greater during the 130% condition compared with 323 
the 70% and 100% conditions. Significant Group*Intensity interactions for VT head and 324 
trunk accelerations indicated that VT acceleration amplitudes were consistent for the PD 325 
Fallers across the walking speeds, but were significantly increased at the fastest speed for PD 326 
Non-Fallers and Older Adults. Furthermore, the significant Group*Intensity interaction for 327 
AP RMS accelerations indicated that PD fallers had significantly greater head accelerations at 328 
the slowest walking speed compared with the 100% and 130% conditions (Table 2). 329 
 330 
INSERT TABLE 2 ABOUT HERE. 331 
 332 
DISCUSSION 333 
The results of this cross-sectional study only partially supported our hypothesis that walking 334 
at speeds slower and faster than preferred would correspond with poorer head and trunk 335 
rhythmicities. As hypothesised, poorer stability was observed for all participant groups at 336 
walking speeds that were slower than preferred, but as walking speed increased, head and 337 
 trunk rhythmicity generally improved as well. These findings are in contrast to previous 338 
research involving healthy younger adults, which showed that pelvic and, to a lesser extent, 339 
head rhythmicities were optimal when participants walked at their preferred speed, but 340 
declined at faster and slower speeds
25
. Similarly, the results of a longitudinal study indicated 341 
that the risk of falling was significantly greater in older adults who walked slower (<0.6 m/s) 342 
or faster (≥1.3 m/s)24, suggesting that stability may be optimised at specific movement 343 
speeds. The disparity between the results of the current study and those presented in this 344 
earlier research may be explained by differences in the coordination and variability of 345 
segmental motion during treadmill and overground walking. For example, research shows 346 
that individuals exhibit reduced variability in their stride-to-stride gait patterns and joint 347 
kinematics during treadmill walking compared with overground gait
70, 71
.  Such differences 348 
are argued to be due to the relatively fewer task constraints imposed by overground walking, 349 
which ultimately gives individuals a greater number of performance options that are equally 350 
appropriate for achieving the desired outcome
71, 72
. Interestingly, the results of this study also 351 
showed that stride timing variability systematically decreased from the slowest to the fastest 352 
walking speed, while separate research examining overground walking in younger adults 353 
reported increased stride time variability at speeds slower and faster than preferred
73
. 354 
Considering that the harmonic ratio provides a measure of the in-phase to out-of-phase 355 
segmental accelerations, it is possible that the improved stability demonstrated by the 356 
participants at the faster speed was reflective of the less variable walking patterns recorded 357 
for these individuals during this condition. 358 
 359 
Despite the results tending to suggest that increased walking speeds lead to improved head 360 
and trunk stability in older adults and people with PD, the post-hoc analyses indicated that 361 
head and trunk accelerations either remained unchanged or decreased at the faster walking 362 
 speed for PD Fallers.  Considering this finding with the overall deficits in head and trunk 363 
control and the increased AP head accelerations that were evident for the PD Fallers, it seems 364 
that these individuals may have a reduced capacity to control these larger segments, which 365 
would directly impact their postural stability. These results are in agreement with previous 366 
research showing that people with PD have significantly greater AP and ML head 367 
accelerations than healthy younger and older adults, which are likely to influence their 368 
capacity to recover from a perturbation
74
.  Collectively, these finding suggest that while some 369 
patients (e.g. PD Non-Fallers) may have the capacity to adapt to the changing demands of a 370 
task, patients who have a history of falls and typically walk at slower preferred speeds may 371 
not. A possible explanation as to why the PD Fallers demonstrated different patterns of head 372 
and trunk control at the faster walking speed might be found in the higher global rigidity 373 
scores reported for these patients at baseline. According to previous research, the rigidity of 374 
the axial system (e.g. trunk, pelvis, neck) significantly increases at faster walking speeds for 375 
people with PD
40
.  Given the axial skeleton essentially serves as a biological shock absorber 376 
to minimise the effects of movement-related forces on the visual and vestibular systems
33-36
, 377 
an increase in the rigidity of this system would likely influence its capacity to perform this 378 
role. As such, the higher prevalence of rigidity evident in the PD fallers may have made these 379 
individuals more susceptible to speed-related changes in axial rigidity and account for a 380 
plateau or decline in head and trunk stability during the faster walking trials. Nevertheless, 381 
the significant decline in some aspects of dynamic stability at the faster walking speed 382 
suggests that the assessment of gait during fast-paced walking may be more suitable for 383 
identifying people with PD who are at an increased risk of falling
75
.  Furthermore, it seems 384 
that if therapists are not monitoring changes in postural stability during gait retraining 385 
programs, it is possible that improvements in gait dynamics may come at the cost of an 386 
increased falls risk for some patients. 387 
  388 
Study Limitations 389 
There are a number of methodological factors that should be considered when reviewing our 390 
results, as they have the potential to limit our capacity to directly compare our findings with 391 
previous research.  First, we elected to conduct our assessments on a motorised treadmill to 392 
strictly control changes in walking speed and to ensure the safety of the participants. 393 
However, previous research has shown that treadmill walking is not a perfect analogue for 394 
overground walking, as it generally returns different values for some spatiotemporal 395 
characteristics
76, 77
, gait variability
71, 77
 and joint kinetics
76, 78
.  Second, the use of tri-axial 396 
accelerometers to assess head and trunk rhythmicity during the walking trials limited our 397 
capacity to objectively evaluate other factors that may potentially have influenced gait 398 
stability (e.g. arm swing, base of support). Although there is a growing body of evidence to 399 
suggest that the size of one’s base of support is not significantly influenced by their walking 400 
speed
79-81
, research has consistently reported a relationship between arm swing and walking 401 
speed in healthy younger
82
 and older adults
83
.  While it remains unclear whether arm swing 402 
directly influences walking stability
84
 or whether it serves to recover a stable walking pattern 403 
following a perturbation
85
, it is important to acknowledge that differences in arm swing 404 
between the groups may have potentially impacted the reported outcomes. Future research 405 
should seek to determine the specific role(s) of arm swing in stabilising the gait patterns of 406 
people with PD and evaluate whether imposed faster and slower walking speeds influence 407 
walking stability in a similar way during overground walking in this population. Despite the 408 
shortcomings of this methodological approach, our findings are likely to be of significant 409 
clinical relevance, as physical therapists are often restricted to using treadmills for gait 410 
retraining due to space limitations and the need to minimise patient risk in the clinical setting. 411 
Furthermore, if we consider that those patients who are most likely to be referred to physical 412 
 therapists for gait retraining are those who present with significant gait disability that limits 413 
their walking speed, then these findings have obvious implications for current practice. 414 
 415 
CONCLUSIONS 416 
While systematic evidence indicates that gait retraining can improve stride length
16-21
, 417 
walking speed
17-23
 and walking distance
22
 in people with PD, the results of this study suggest 418 
that these changes may lead to an increased risk of future falls for some patients if postural 419 
stability is not targeted. As such, we recommend that gait retraining should not be 420 
implemented as a stand-alone therapy for high-risk PD patients, but rather should be coupled 421 
with other physical therapy that seeks to address any underlying balance impairments that 422 
may be present for an individual.  423 
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 FIGURE LEGENDS 643 
Fig. 1: Mean (+1 SD) walking speeds, stride lengths, cadences and stride time variability for 644 
the PD fallers, PD Non-Fallers and age-matched Older Adults while walking on the treadmill 645 
at 70%, 100% and 130% of their preferred walking speed. 646 
 647 
Fig. 2: Estimated Marginal Means (EMM) and standard errors (SE) for the head and trunk 648 
harmonic ratios (adjusted for walking speed and stride time variability) for the PD fallers, PD 649 
Non-Fallers and Older Adults while walking on the treadmill at 70%, 100% and 130% of 650 
their preferred walking speed. Note: Larger harmonic ratios depict a greater proportion of in-651 
phase relative to out-of-phase accelerations and, hence represent more stable gait patterns. 652 
 653 
Fig. 3: Estimated Marginal Means (EMM) and standard errors (SE) for head and trunk RMS 654 
accelerations (adjusted for walking speed and stride time variability) for the PD fallers, PD 655 
Non-Fallers and age-matched Older Adults while walking on the treadmill at 70%, 100% and 656 
130% of their preferred walking speed. 657 
 658 
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Table 1: Demographic data and disease-specific scores for the participants with PD Fallers, 
PD Non-Fallers and the age-matched Older Adults. Data represent the mean (standard error 
of the mean (SEM)) values or absolute numbers and percentages. Test 1 = one-way ANOVA; 
Test 2 = Kruskal-Wallis Test; Test 3 = χ2 test. 
ns: No significant differences between groups; a: PD Fallers significantly different to PD Non-Fallers; b: PD Fallers 
significantly different to Older Adults; c: PD Non-Fallers significantly different to Older Adults 
       PD Fallers PD Non-Fallers Older Adults Test Sig 
Demographics      
Age (Years) 69.3 (2.2) 66.5 (2.5) 68.6 (2.8) 1 ns 
Gender (Male) 6 (60.0%) 6 (60.0%) 6 (60.0%) 3 ns 
Height (cm) 165.7 (3.5) 168.5 (3.8) 168.7 (2.7) 1 ns 
Ns 
ns 
Mass (kg) 65.9 (6.2) 67.9 (3.8) 65.9 (3.1) 1 ns 
      
Falls History and Fear of Falls      
Activities-Specific Balance Confidence 59.3 (8.9) 78.7 (4.7) 82.3 (7.0) 2 ns 
Previous Falls (12 months) 9.5 (4.8) 0.0 (0.0) 0.4 (0.2) 2 a, b 
      
Quality of Life      
8-item Parkinson’s Disease Questionnaire 28.8 (4.9) 14.4 (2.1)  2 a 
      
Neurological Exam      
Disease Duration (years) 7.0 (1.7) 4.6 (0.6)  2 ns 
Levodopa (mg/day) 810.8 (147.8) 451.6 (102.9)  1 ns 
Dopamine Agonists 2 (20.0%) 2 (20.0%)  3 ns 
Catechol-O-Methyl Transferase Inhibitors 2 (20.0%) 2 (20.0%)  3 ns 
Monoamine Oxidase Inhibitors 6 (60.0%) 3 (30.0%)  3 ns 
Benzodiazepine 0 (0.0%) 0 (0.0%)  3 ns 
No Medication 0 (0.0%) 1 (10.0%)  3 ns 
UPDRS III 22.6 (1.9) 13.1 (2.1)  1 a 
Hoehn & Yahr Stage Score 2.2 (0.2) 1.4 (0.2)  2 a 
Schwab & England ADL Scale 77.0 (2.4) 89.5 (2.0)  1 a 
Revised Freezing of Gait Score 10.8 (3.2) 2.1 (2.1)  2 a 
      
      
Table 2: Estimated Marginal Means (EMM) and standard errors (SE) for the head and trunk harmonic ratios and RMS accelerations (adjusted for walking speed 
and stride time variability) for the PD fallers, PD Non-Fallers and Older Adults while walking on the treadmill at 70%, 100% and 130% of their preferred walking 
speed. Note: Larger harmonic ratios depict a greater proportion of in-phase relative to out-of-phase accelerations and, hence represent more rhythmic gait patterns. 
      70% Preferred Walking Speed 100% Preferred Walking Speed 130% Preferred Walking Speed  
 PD Fallers PD Non-Fallers Older Adults PD Fallers PD Non-Fallers Older Adults PD Fallers PD Non-Fallers Older Adults Sig 
 EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE)  
           
Harmonic Ratios           
 Anteroposterior 1.54 (0.08) 1.69 (0.06) 1.63 (0.06) 1.86 (0.06) 1.75 (0.05) 1.85 (0.06) 1.77 (0.05) 1.93 (0.06) 1.96 (0.07) ¥, §, † 
Head Mediolateral 1.74 (0.08) 2.27 (0.07) 2.84 (0.07) 1.94 (0.06) 2.46 (0.06) 2.95 (0.06) 2.15 (0.06) 2.61 (0.07) 3.15 (0.08) a, b, c, ¥, Ŧ, § 
 Vertical 2.22 (0.10) 2.54 (0.08) 2.75 (0.09) 2.52 (0.08) 2.73 (0.07) 3.19 (0.08) 2.34 (0.08) 2.89 (0.09) 3.40 (0.10) a, b, c, ¥, §, † 
            Anteroposterior 2.08 (0.09) 2.37 (0.08) 2.30 (0.08) 2.15 (0.07) 2.24 (0.07) 2.71 (0.08) 1.68 (0.07) 2.55 (0.08) 2.67 (0.09) a, b, c, ¥, † 
Trunk Mediolateral 1.96 (0.10) 2.14 (0.08) 2.26 (0.09) 2.14 (0.08) 2.24 (0.07) 2.68 (0.08) 2.24 (0.07) 2.56 (0.09) 3.07 (0.10) a, b, c, ¥, Ŧ, §, † 
 Vertical 2.46 (0.12) 2.94 (0.10) 3.02 (0.10) 2.82 (0.10) 3.01 (0.09) 3.53 (0.10) 2.50 (0.09) 3.12 (0.10) 3.77 (0.12) a, b, c, ¥, §, † 
           
RMS Acceleration (m/s
2
)          
 Anteroposterior 1.17 (0.10) 0.79 (0.10) 0.72 (0.10) 1.09 (0.10) 0.61 (0.10) 0.57 (0.10) 0.88 (0.10) 0.62 (0.10) 0.51 (0.10) a, b, ¥, § 
Head Mediolateral 1.33 (0.11) 0.90 (0.11) 1.02 (0.11) 1.11 (0.11) 0.76 (0.11) 0.83 (0.11) 0.98 (0.11) 0.77 (0.11) 0.78 (0.11) ¥, § 
 Vertical 1.85 (0.12) 1.51 (0.12) 1.41 (0.12) 1.79 (0.12) 1.47 (0.12) 1.52 (0.12) 1.80 (0.12) 1.76 (0.12) 1.78 (0.12) Ŧ, §, † 
            Anteroposterior 1.02 (0.07) 0.78 (0.07) 0.71 (0.07) 0.91 (0.07) 0.79 (0.07) 0.72 (0.07) 0.84 (0.07) 0.91 (0.07) 0.75 (0.07) † 
Trunk Mediolateral 1.66 (0.14) 1.24 (0.14) 1.18 (0.14) 1.39 (0.14) 0.99 (0.14) 0.95 (0.14) 1.16 (0.14) 1.00 (0.14) 0.92 (0.14) ¥, § 
 Vertical 2.05 (0.14) 1.46 (0.14) 1.46 (0.14) 2.03 (0.14) 1.53 (0.14) 1.62 (0.14) 2.04 (0.14) 1.93 (0.14) 1.89 (0.14) Ŧ, §, † 
           
ns: No significant differences between groups; a: PD Fallers significantly different to PD Non-Fallers; b: PD Fallers significantly different to Older Adults; c: PD Non-Fallers significantly 
different to Older Adults; ¥ 70% significantly different to 100%; Ŧ 100% significantly different to 130%; § 70% significantly different to 130%; † significant Group*Speed interaction. 
Highlights 
 Parkinson’s patients with a falls history had poorer rhythmicity at all gait speeds 
 Improvements in walking speed do not necessarily imply improved postural stability 
 Combining gait retraining with other therapies may benefit high-risk Parkinson’s patients 
 
